Cargando…
Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone
Inflammation is increasingly recognized as a driver of hypertension. Both genetic and pharmacological inhibition of B and T cells attenuates most forms of experimental hypertension. Accordingly, the immunosuppressive drug mycophenolate mofetil (MMF) reduces blood pressure in the deoxycorticosterone...
Autores principales: | Moes, Arthur D., Severs, David, Verdonk, Koen, van der Lubbe, Nils, Zietse, Robert, Danser, A. H. J., Hoorn, Ewout J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968119/ https://www.ncbi.nlm.nih.gov/pubmed/29867591 http://dx.doi.org/10.3389/fphys.2018.00578 |
Ejemplares similares
-
Mycophenolate Improves Brain–Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats
por: Robles-Vera, Iñaki, et al.
Publicado: (2020) -
SIADH and hyponatraemia: why does it matter?
por: Hoorn, Ewout J., et al.
Publicado: (2009) -
Current and future treatment options in SIADH
por: Zietse, Robert, et al.
Publicado: (2009) -
Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
por: Cerrudo, Carolina S., et al.
Publicado: (2021) -
Aldosterone does not require angiotensin II to activate NCC through a WNK4–SPAK–dependent pathway
por: van der Lubbe, Nils, et al.
Publicado: (2012)